SUBJECTS : Biliary Tract Diseases | Liver Disease
Clinical and Molecular Hepatology: 2023, vol: 29, issue: 4
- 1)- Vy H Nguyen, Isaac Le, Audrey Ha, Richard Hieu Le, Nicholas Ajit Rouillard, Ashley Fong, Surya Gudapati, Jung Eun Park, Mayumi Maeda, Scott Barnett, Ramsey Cheung, Mindie H Nguyen. Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study. Clinical and molecular hepatology. 2023, 29 (4): 1002-1012
Cited : 1Read More - 2)- Ha Il Kim, Jihyun An, Seungbong Han, Ju Hyun Shim. Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis. Clinical and molecular hepatology. 2023, 29 (4): 1013-1028Cited : 3Read More
- 3)- Jeongin Yoo, Heejin Cho, Dong Ho Lee, Eun Ju Cho, Ijin Joo, Sun Kyung Jeon. Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection. Clinical and molecular hepatology. 2023, 29 (4): 1029-1042Cited : 0Read More
- 4)- Daphne J Theodorou, Stavroula J Theodorou, Ioannis V Mitselos. Letter regarding "Evidence-based hyponatremia management in liver disease". Clinical and molecular hepatology. 2023, 29 (4): 1043-1045Cited : 1Read More
- 5)- Abhijit Pratap, Umesh More, Pradnya Phalak, Anita Deshmukh. Letter regarding "Risk factors in nonalcoholic fatty liver disease". Clinical and molecular hepatology. 2023, 29 (4): 1046-1047Cited : 1Read More
- 6)- Ji Young Ryu, Seon Ha Baek, Sejoong Kim. Correspondence on Letter regarding "Evidence-based hyponatremia management in liver disease". Clinical and molecular hepatology. 2023, 29 (4): 1048-1049Cited : 0Read More
- 7)- Eileen L Yoon, Dae Won Jun. Correspondence on Letter regarding "Risk factors in nonalcoholic fatty liver disease". Clinical and molecular hepatology. 2023, 29 (4): 1050-1051Cited : 0Read More
- 8)- Qiankun Luo, Pan Liu, Yifei Dong, Tao Qin. The role of the hepatic autonomic nervous system. Clinical and molecular hepatology. 2023, 29 (4): 1052-1055Cited : 0Read More
- 9)- Gi-Ae Kim, Joon Ho Moon, Won Kim. Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity. Clinical and molecular hepatology. 2023, 29 (4): 831-843Cited : 20Read More
- 10)- Eileen L Yoon, Dae Won Jun. Waiting for the changes after the adoption of steatotic liver disease. Clinical and molecular hepatology. 2023, 29 (4): 844-850Cited : 15Read More
- 11)- Landon L Chan, Stephen L Chan. The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment. Clinical and molecular hepatology. 2023, 29 (4): 909-923Cited : 5Read More
- 12)- Ji Young Ryu, Seon Ha Baek, Sejoong Kim. Evidence-based hyponatremia management in liver disease. Clinical and molecular hepatology. 2023, 29 (4): 924-944Cited : 4Read More
- 13)- Hwa Kyung Byun, Changhwan Kim, Jinsil Seong. Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma. Clinical and molecular hepatology. 2023, 29 (4): 945-957Cited : 3Read More
- 14)- Sung Uk Lee, Tae Hyun Kim. Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma. Clinical and molecular hepatology. 2023, 29 (4): 958-968Cited : 2Read More
- 15)- Ming-Lun Yeh, Ming-Lung Yu. From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials. Clinical and molecular hepatology. 2023, 29 (4): 969-972Cited : 4Read More
- 16)- Jacob George. Adding to the confusion in more than just the name. Clinical and molecular hepatology. 2023, 29 (4): 973-976Cited : 5Read More
- 17)- Sang Min Yoon. Novel paradigm in the treatment of hepatocellular carcinoma: Anticipating breakthroughs with particle therapy. Clinical and molecular hepatology. 2023, 29 (4): 977-979Cited : 0Read More
- 18)- Eugene Han, Yong-Ho Lee. Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean? Clinical and molecular hepatology. 2023, 29 (4): 980-983Cited : 1Read More
- 19)- Hyo-Cheol Kim. Chemoembolization combined with radiofrequency ablation is the best option for the local treatment of early hepatocellular carcinoma? Clinical and molecular hepatology. 2023, 29 (4): 984-986Cited : 0Read More
- 20)- Hong-Kyu Kim, Sung-Jin Bae, Min Jung Lee, Eun Hee Kim, Hana Park, Hwi Seung Kim, Yun Kyung Cho, Chang Hee Jung, Woo Je Lee, Jaewon Choe. Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity. Clinical and molecular hepatology. 2023, 29 (4): 987-1001Cited : 9Read More
